Deena Brosi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Deena Brosi has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Jesse D. Schold
Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
11 shared publications - Susana Arrigain
Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado
10 shared publications - Rocio Lopez
Division of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Colorado Center for Transplantation Care (CCTCARE), Research and Education, Division of Transplant Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado, Aurora, Colorado
9 shared publications - Sumit Mohan
Division of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York
8 shared publications - Ryan LaVanchy
Division of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Colorado Center for Transplantation Care (CCTCARE), Research and Education, Division of Transplant Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado, Aurora, Colorado
7 shared publications - Elizabeth Anne Pomfret
University of Colorado School of Medicine
6 shared publications
Latest Publications
- 27 October 2026
- Published by Wiley in Transplant Infectious Disease
Cytomegalovirus Donor and Recipient Serostatus and 5‐Year Mortality After Heart Transplantation: Evidence of Racial Differences
Background: Cytomegalovirus (CMV) donor/recipient (D/R) serostatus is an established determinant of post‐transplant outcomes in heart transplantation (HT); however, the extent to which demographic and socioeconomic (SE) factors modify CMV‐related mortality risk remains unclear. Methods: Using the scientific registry of transplant recipients, we evaluated whether demographic and SE factors alter the association between CMV D/R serostatus and 5‐year all‐cause mortality among first‐time, adult HT recipients (2010–2024). Multivariable competing risk models estimated sub‐distribution hazard ratios (sHRs) for CMV D/R serostatus interacted with age, sex, race/ethnicity, and Distressed Community Index (DCI) categories. Results: CMV D+/R− and CMV D+/R+ serostatus were associated with increased 5‐year mortality. Effect modification varied by subgroup. Age, sex, and DCI did not significantly modify CMV‐associated mortality, suggesting consistent relative risk across these strata. In contrast, race/ethnicity significantly modified the association with attenuated mortality among Black HT recipients compared with White HT recipients (reference). The sHR for mortality comparing Black CMV D−/R− and CMV D+/R+ HT recipients was 0.69 lower (95% CI: 0.57–0.84; p ‐value < 0.001) than the corresponding estimate in White HT recipients. Similarly, the sHR comparing Black CMV D−/R− and CMV D−/R+ HT recipients was 0.78 lower (95% CI: 0.63–0.97; p ‐value = 0.024) than the White HT recipients. No significant differences were observed between White and Hispanic/Other racial/ethnic groups. Conclusions: CMV‐related mortality risk was evident among White recipients, however, the effect of CMV on post‐transplant outcomes is attenuated in Black recipients. These findings highlight heterogeneity in CMV‐associated risk and support more individualized CMV prevention and monitoring strategies incorporating demographic context.
- 27 October 2026
- Published by Wiley in Transplant Infectious Disease
Cytomegalovirus Donor and Recipient Serostatus and 5‐Year Mortality After Heart Transplantation: Evidence of Racial Differences
Background: Cytomegalovirus (CMV) donor/recipient (D/R) serostatus is an established determinant of post‐transplant outcomes in heart transplantation (HT); however, the extent to which demographic and socioeconomic (SE) factors modify CMV‐related mortality risk remains unclear. Methods: Using the scientific registry of transplant recipients, we evaluated whether demographic and SE factors alter the association between CMV D/R serostatus and 5‐year all‐cause mortality among first‐time, adult HT recipients (2010–2024). Multivariable competing risk models estimated sub‐distribution hazard ratios (sHRs) for CMV D/R serostatus interacted with age, sex, race/ethnicity, and Distressed Community Index (DCI) categories. Results: CMV D+/R− and CMV D+/R+ serostatus were associated with increased 5‐year mortality. Effect modification varied by subgroup. Age, sex, and DCI did not significantly modify CMV‐associated mortality, suggesting consistent relative risk across these strata. In contrast, race/ethnicity significantly modified the association with attenuated mortality among Black HT recipients compared with White HT recipients (reference). The sHR for mortality comparing Black CMV D−/R− and CMV D+/R+ HT recipients was 0.69 lower (95% CI: 0.57–0.84; p ‐value < 0.001) than the corresponding estimate in White HT recipients. Similarly, the sHR comparing Black CMV D−/R− and CMV D−/R+ HT recipients was 0.78 lower (95% CI: 0.63–0.97; p ‐value = 0.024) than the White HT recipients. No significant differences were observed between White and Hispanic/Other racial/ethnic groups. Conclusions: CMV‐related mortality risk was evident among White recipients, however, the effect of CMV on post‐transplant outcomes is attenuated in Black recipients. These findings highlight heterogeneity in CMV‐associated risk and support more individualized CMV prevention and monitoring strategies incorporating demographic context.
- 4 August 2026
- Published by Wolters Kluwer Health in Liver Transplantation
Candidates for liver transplant with high-frequency deceased donor offers
Changes in organ allocation, technology, and regulatory policy have led to significant increases in deceased donor liver offers for transplantation. Expansion of potential donors is associated with inefficiencies, including increased liver nonutilization, resources, and complications. We evaluated the contribution of individual waitlisted candidates to the national allocation of deceased donor liver offers to understand characteristics of candidates with numerous offer turndowns. We performed an observational cohort study of the Scientific Registry of Transplant Recipients, including deceased donor liver offers in the United States between January 1, 2021, and December 31, 2024. We used standard and hierarchical multivariable logistic models to evaluate factors associated with high-frequency candidates (HFCs). There were 1,021,569 offers of 32,750 deceased donor livers to 55,124 waitlisted candidates with ≥1 offer. Waitlisted candidates had 10.4 months average waitlist follow-up and received a median of 9 (IQR=[4, 22]) offers. However, 46% of offers (n=468,699) went to 10% (HFC, n=5726), who had ≥45 offers over the period. HFC were disproportionally ages 18–39 (adjusted odds ratio [AOR]=1.58, 95% CI=1.33–1.86, relative to 70+), Black (AOR=1.31, 95% CI: 1.17–1.47, relative to White), type-O blood (AOR=1.14, 95% CI: 1.07–1.21, relative to type A), body mass index ≥35 kg/m 2 (AOR=1.17, 95% CI: 1.06–1.28, relative to body mass index=20–24 kg/m 2 ), MELD 12–17 (AOR=1.24, 95% CI: 1.15–1.34, relative to >25), metabolic dysfunction (AOR=1.32, 95% CI: 1.09–1.62, relative to cirrhosis) and history of portal vein thrombosis (AOR=1.34, 95% CI: 1.23–1.46). There was significant heterogeneity in HFC by transplant center (median=8%, IQR=[3%, 13%]), and centers with higher proportions of HFC had lower transplant rates and offer acceptance ratios ( p <0.001). HFCs who received transplants had fewer living donor transplants and transplanted with older age donors. Results indicate liver donor offers are disproportionately explained by a minority of candidates. Efforts to identify reasons for repetitive offer declines, strategic use of offer filters and transition of applicable candidates to inactive status may dramatically improve the efficiency of deceased donor liver allocation.
- 4 August 2026
- Published by Wolters Kluwer Health in Liver Transplantation
Candidates for liver transplant with high-frequency deceased donor offers
Changes in organ allocation, technology, and regulatory policy have led to significant increases in deceased donor liver offers for transplantation. Expansion of potential donors is associated with inefficiencies, including increased liver nonutilization, resources, and complications. We evaluated the contribution of individual waitlisted candidates to the national allocation of deceased donor liver offers to understand characteristics of candidates with numerous offer turndowns. We performed an observational cohort study of the Scientific Registry of Transplant Recipients, including deceased donor liver offers in the United States between January 1, 2021, and December 31, 2024. We used standard and hierarchical multivariable logistic models to evaluate factors associated with high-frequency candidates (HFCs). There were 1,021,569 offers of 32,750 deceased donor livers to 55,124 waitlisted candidates with ≥1 offer. Waitlisted candidates had 10.4 months average waitlist follow-up and received a median of 9 (IQR=[4, 22]) offers. However, 46% of offers (n=468,699) went to 10% (HFC, n=5726), who had ≥45 offers over the period. HFC were disproportionally ages 18–39 (adjusted odds ratio [AOR]=1.58, 95% CI=1.33–1.86, relative to 70+), Black (AOR=1.31, 95% CI: 1.17–1.47, relative to White), type-O blood (AOR=1.14, 95% CI: 1.07–1.21, relative to type A), body mass index ≥35 kg/m 2 (AOR=1.17, 95% CI: 1.06–1.28, relative to body mass index=20–24 kg/m 2 ), MELD 12–17 (AOR=1.24, 95% CI: 1.15–1.34, relative to >25), metabolic dysfunction (AOR=1.32, 95% CI: 1.09–1.62, relative to cirrhosis) and history of portal vein thrombosis (AOR=1.34, 95% CI: 1.23–1.46). There was significant heterogeneity in HFC by transplant center (median=8%, IQR=[3%, 13%]), and centers with higher proportions of HFC had lower transplant rates and offer acceptance ratios ( p <0.001). HFCs who received transplants had fewer living donor transplants and transplanted with older age donors. Results indicate liver donor offers are disproportionately explained by a minority of candidates. Efforts to identify reasons for repetitive offer declines, strategic use of offer filters and transition of applicable candidates to inactive status may dramatically improve the efficiency of deceased donor liver allocation.
- Open Access
How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations
Background/Objectives: COVID-19 vaccine resistance was detrimental to herd immunity and worsened COVID-19 morbidity and mortality during outbreaks. Despite more evidence showing reactionary behavior among residents exposed to vaccine mandates, little research has been conducted on the effects of state proof-of-vaccine (POV) mandate bans in the United States (US). We sought to investigate the causal effects of POV mandate bans, overall and stratified by policy passage via executive order or state legislature, on first-dose COVID-19 vaccinations. Methods: In the contiguous US, 21 states enacted POV mandate bans from 8 February 2021–25 October 2021. Using a geographic regression discontinuity design, we selected treatment and control counties within 150 miles of the POV mandate ban state border. The resulting sample was 4612 county-observations and 2466 unique counties. We conducted two-way fixed-effects estimation to compare changes in weekly, first-dose COVID-19 vaccinations among individuals <65 years old before and after POV mandate ban enactment between treatment and control counties. Results: Among executive order POV mandate ban counties, we saw an additional increase in weekly, first-dose COVID-19 vaccinations following POV mandate ban enactment when compared to controls. There was an additional 38.2% increase in Weeks 1–2, 40.6% in Weeks 3–4, 41.3% in Weeks 5–6, and 43.9% in Weeks 7–8. Conclusions: While seemingly counterintuitive, these findings follow Psychological Reactance Theory. Once the perceived threat to freedom was removed, reactance to COVID-19 vaccinations declined and constituents received the COVID-19 vaccine of their own volition. Future public health efforts should consider potential reactance to mandatory policies and tailor efforts to community values.
Open AccessHow Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations
Background/Objectives: COVID-19 vaccine resistance was detrimental to herd immunity and worsened COVID-19 morbidity and mortality during outbreaks. Despite more evidence showing reactionary behavior among residents exposed to vaccine mandates, little research has been conducted on the effects of state proof-of-vaccine (POV) mandate bans in the United States (US). We sought to investigate the causal effects of POV mandate bans, overall and stratified by policy passage via executive order or state legislature, on first-dose COVID-19 vaccinations. Methods: In the contiguous US, 21 states enacted POV mandate bans from 8 February 2021–25 October 2021. Using a geographic regression discontinuity design, we selected treatment and control counties within 150 miles of the POV mandate ban state border. The resulting sample was 4612 county-observations and 2466 unique counties. We conducted two-way fixed-effects estimation to compare changes in weekly, first-dose COVID-19 vaccinations among individuals <65 years old before and after POV mandate ban enactment between treatment and control counties. Results: Among executive order POV mandate ban counties, we saw an additional increase in weekly, first-dose COVID-19 vaccinations following POV mandate ban enactment when compared to controls. There was an additional 38.2% increase in Weeks 1–2, 40.6% in Weeks 3–4, 41.3% in Weeks 5–6, and 43.9% in Weeks 7–8. Conclusions: While seemingly counterintuitive, these findings follow Psychological Reactance Theory. Once the perceived threat to freedom was removed, reactance to COVID-19 vaccinations declined and constituents received the COVID-19 vaccine of their own volition. Future public health efforts should consider potential reactance to mandatory policies and tailor efforts to community values.
- 22 May 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (10) , 2315-2326
Contribution of donor hospital characteristics to deceased donor organ recovery rates
- 22 May 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (10) , 2315-2326
Contribution of donor hospital characteristics to deceased donor organ recovery rates
- Open Access
- 21 April 2026
- Published by MDPI AG in Preprints.org
How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations
Background/Objectives: COVID-19 vaccine resistance was detrimental to herd immunity and worsened COVID-19 morbidity and mortality during outbreaks. Despite more evidence showing reactionary behavior among residents exposed to vaccine mandates, little research has been conducted on the effects of state proof-of-vaccine (POV) mandate bans in the United States (US). We sought to investigate the causal effects of POV mandate bans, overall and stratified by policy passage via executive order or state legislature, on 1st-dose COVID-19 vaccinations. Methods: In the contiguous US, 21 states enacted POV mandate bans from 2/8/2021–10/25/2021. Using a geographic regression discontinuity design, we selected treatment and control counties within 150 miles of the POV mandate ban state border. The resulting sample was 4,612 county-observations and 2,466 unique counties. We conducted two-way fixed effects estimation to compare changes in bimonthly, 1st-dose COVID-19 vaccinations among individuals under 65 years old before and after POV mandate ban enactment between treatment and control counties. Results: Among executive order POV mandate ban counties, we saw a reduction in the decreasing 1st-dose COVID-19 trend following POV mandate ban enactment. This corresponded to an additional 32.6% increase in 1st-dose COVID-19 vaccinations in Weeks 1–2, 34.5% in Weeks 3–4, 35.0% in Weeks 5–6, and 36.9% in Weeks 7–8 post-POV mandate ban enactment when compared to control counties. Conclusions: These findings suggest that executive order POV mandate bans reversed reactance to vaccine mandates. Future public health efforts should consider potential reactance to mandatory policies and tailor efforts to community values.
- 21 April 2026
- Published by MDPI AG in Preprints.org
Open AccessHow Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations
Background/Objectives: COVID-19 vaccine resistance was detrimental to herd immunity and worsened COVID-19 morbidity and mortality during outbreaks. Despite more evidence showing reactionary behavior among residents exposed to vaccine mandates, little research has been conducted on the effects of state proof-of-vaccine (POV) mandate bans in the United States (US). We sought to investigate the causal effects of POV mandate bans, overall and stratified by policy passage via executive order or state legislature, on 1st-dose COVID-19 vaccinations. Methods: In the contiguous US, 21 states enacted POV mandate bans from 2/8/2021–10/25/2021. Using a geographic regression discontinuity design, we selected treatment and control counties within 150 miles of the POV mandate ban state border. The resulting sample was 4,612 county-observations and 2,466 unique counties. We conducted two-way fixed effects estimation to compare changes in bimonthly, 1st-dose COVID-19 vaccinations among individuals under 65 years old before and after POV mandate ban enactment between treatment and control counties. Results: Among executive order POV mandate ban counties, we saw a reduction in the decreasing 1st-dose COVID-19 trend following POV mandate ban enactment. This corresponded to an additional 32.6% increase in 1st-dose COVID-19 vaccinations in Weeks 1–2, 34.5% in Weeks 3–4, 35.0% in Weeks 5–6, and 36.9% in Weeks 7–8 post-POV mandate ban enactment when compared to control counties. Conclusions: These findings suggest that executive order POV mandate bans reversed reactance to vaccine mandates. Future public health efforts should consider potential reactance to mandatory policies and tailor efforts to community values.
- 8 April 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (8) , 1933-1945
How contemporary living kidney donor transplants compare to prepandemic trends: An interrupted time series analysis
- 8 April 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (8) , 1933-1945
How contemporary living kidney donor transplants compare to prepandemic trends: An interrupted time series analysis
- Open Access
- 13 November 2025
- Published by Elsevier in Kidney International Reports
- Vol. 11 (2) , 103678
Recipient Human Leukocyte Antigen-DR Homozygosity and Access to Quality Kidneys
- 13 November 2025
- Published by Elsevier in Kidney International Reports
- Vol. 11 (2) , 103678
Open AccessRecipient Human Leukocyte Antigen-DR Homozygosity and Access to Quality Kidneys
- Open Access
- 21 May 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (10) , 2151-2160
Evaluation of the stability of organ procurement organization performance metrics
- 21 May 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (10) , 2151-2160
Open AccessEvaluation of the stability of organ procurement organization performance metrics
- 6 May 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (10) , 2019-2029
Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States
Key Points: In 2023, national policy mandated that kidney transplant centers identify Black candidates for potential waitlist priority modification. Overall, 32% of Black candidates received modification with significant variation by candidate characteristics and transplant center. Candidates who received modification had close to three-fold higher rates of deceased donor transplantation. Background: In 2023, kidney transplant programs in the United States were mandated by the Organ Procurement and Transplantation Network (OPTN) to identify all Black candidates on their kidney waiting lists and evaluate potential modifications of waiting time. This mandate was the result of established differences in eligibility for candidates to receive priority for donor offers based on race-neutral and race-inclusive eGFR. The policy went into effect on January 5, 2023, and required submission of appropriate modifications with a deadline of January 3, 2024. Methods: We included OPTN data for adult Black candidates on the kidney and kidney/pancreas transplant waiting lists in the United States between January 6, 2023, and December 31, 2023. We evaluated incidence of wait time modifications based on eGFR, characterized candidates with and without modifications, heterogeneity in center-level implementation of eGFR modifications, and the association of modification with time to deceased donor transplantation using multivariable generalized estimating equations and Cox models. Results: Overall, 32% (14,419/44,912) of Black candidate listings received an eGFR modification of waiting time priority. In multivariable analysis, candidates with modifications were older (compared with candidates aged 18–49, ages 65–69 and 70+ had adjusted odds ratio [aOR]=1.60 [95% confidence interval (CI), 1.49 to 1.72] and 1.52 [95% CI, 1.40 to 1.66] respectively), female (aOR=1.09, 95% CI, 1.04 to 1.14), and preemptively placed on the waiting list (aOR=2.58, 95% CI, 2.46 to 2.72). Kidney-alone candidates (versus kidney-pancreas candidates), candidates with higher body mass index, and prior transplant recipients also had higher adjusted likelihood of waiting time modification. The median increase in qualifying priority days for candidates was 610 (interquartile range=330–1049). Waitlist modification was associated with a significantly higher rate of deceased donor transplantation (adjusted hazard ratio=2.85 [95% CI, 2.70 to 3.02]). There was significant variation by transplant center in the proportion of prevalent patients with modifications (median=31%, interquartile range=11%–45%). Conclusions: There was significant patient- and center-level variation in the implementation of eGFR modifications and a higher rate of transplantation for candidates who received modifications.
- 6 May 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (10) , 2019-2029
Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States
Key Points: In 2023, national policy mandated that kidney transplant centers identify Black candidates for potential waitlist priority modification. Overall, 32% of Black candidates received modification with significant variation by candidate characteristics and transplant center. Candidates who received modification had close to three-fold higher rates of deceased donor transplantation. Background: In 2023, kidney transplant programs in the United States were mandated by the Organ Procurement and Transplantation Network (OPTN) to identify all Black candidates on their kidney waiting lists and evaluate potential modifications of waiting time. This mandate was the result of established differences in eligibility for candidates to receive priority for donor offers based on race-neutral and race-inclusive eGFR. The policy went into effect on January 5, 2023, and required submission of appropriate modifications with a deadline of January 3, 2024. Methods: We included OPTN data for adult Black candidates on the kidney and kidney/pancreas transplant waiting lists in the United States between January 6, 2023, and December 31, 2023. We evaluated incidence of wait time modifications based on eGFR, characterized candidates with and without modifications, heterogeneity in center-level implementation of eGFR modifications, and the association of modification with time to deceased donor transplantation using multivariable generalized estimating equations and Cox models. Results: Overall, 32% (14,419/44,912) of Black candidate listings received an eGFR modification of waiting time priority. In multivariable analysis, candidates with modifications were older (compared with candidates aged 18–49, ages 65–69 and 70+ had adjusted odds ratio [aOR]=1.60 [95% confidence interval (CI), 1.49 to 1.72] and 1.52 [95% CI, 1.40 to 1.66] respectively), female (aOR=1.09, 95% CI, 1.04 to 1.14), and preemptively placed on the waiting list (aOR=2.58, 95% CI, 2.46 to 2.72). Kidney-alone candidates (versus kidney-pancreas candidates), candidates with higher body mass index, and prior transplant recipients also had higher adjusted likelihood of waiting time modification. The median increase in qualifying priority days for candidates was 610 (interquartile range=330–1049). Waitlist modification was associated with a significantly higher rate of deceased donor transplantation (adjusted hazard ratio=2.85 [95% CI, 2.70 to 3.02]). There was significant variation by transplant center in the proportion of prevalent patients with modifications (median=31%, interquartile range=11%–45%). Conclusions: There was significant patient- and center-level variation in the implementation of eGFR modifications and a higher rate of transplantation for candidates who received modifications.
- Open Access
- 8 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1756-1764
Association of the initial implementation of continuous distribution allocation policy with outcomes for lung transplant candidates by blood type
- 8 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1756-1764
Open AccessAssociation of the initial implementation of continuous distribution allocation policy with outcomes for lung transplant candidates by blood type